CERT logo

CERT

Certara Inc.

$5.35
+$0.14(+2.69%)
50
Overall
60
Value
33
Tech
57
Quality
How is this score calculated?
Market Cap
$810.49M
Volume
4.52M
52W Range
$4.45 - $13.88
Target Price
$7.80

Company Overview

Mkt Cap$810.49MPrice$5.35
Volume4.52MChange+2.69%
P/E Ratio-508.1Open$5.22
Revenue$418.8MPrev Close$5.21
Net Income$-1.6M52W Range$4.45 - $13.88
Div YieldN/ATarget$7.80
Overall50Value60
Quality57Technical33

No chart data available

About Certara Inc.

Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Sector: Technology
Industry: Software Publishers

Latest News

Certara Shareholders Back Directors, Auditor and Executive Pay

Certara ( ($CERT) ) has shared an update. On May 14, 2026, Certara, Inc. held its annual meeting of stockholders, where investors elected three Cla...

TipRanks Auto-Generated Newsdesk12 days ago

Analysts Offer Insights on Healthcare Companies: Certara (CERT) and Dyne Therapeutics (DYN)

Christine Brown16 days ago

Analysts Offer Insights on Healthcare Companies: Certara (CERT) and Dyne Therapeutics (DYN)

Christine Brown16 days ago

Analysts’ Top Healthcare Picks: Certara (CERT), Gilead Sciences (GILD)

Howard Kim16 days ago

Analysts’ Top Healthcare Picks: Certara (CERT), Gilead Sciences (GILD)

Howard Kim16 days ago
ABCD
1SymbolPriceChangeVol
2CERT$5.35+2.7%4.52M
3
4
5
6

Get Certara Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.